TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06050707: MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

Sponsor: University Health Network, Toronto · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 80 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$8,778,000

Rescue Site Savings

+$5,775,000

Unlock Full NCT06050707 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06050707 Rescue Dossier →